Publications

2024

de Cos M, Mosoyan G, Chauhan K, Troost JP, Wong JS, Lefferts S, et al. Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease. Am J Kidney Dis. 2024.
Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, et al. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. Eur Urol. 2024;85(4):361-372.
van Wyk AC, Lal P, J Ogunbiyi O, Kyokunda L, Hobenu F, Dial C, et al. Multinational, Multicenter Evaluation of Prostate Cancer Tissue in Sub-Saharan Africa: Challenges and Opportunities. JCO Glob Oncol. 2024;10:e2300403.
Lacunza E, Ahuja A, Coso OA, Abba M, Ramos JC, Cesarman E, et al. Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiation. J Med Virol. 2024;96(5):e29684.
Sumiyoshi T, Wang X, Warner EW, Sboner A, Annala M, Sigouros M, et al. Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial. J Natl Cancer Inst. 2024;116(1):115-126.
Mueller FB, Yang H, Li C, Dadhania DM, Xiang JZ, Salvatore SP, et al. RNA-sequencing of Human Kidney Allografts and Delineation of T-Cell Genes, Gene Sets, and Pathways Associated With Acute T Cell-mediated Rejection. Transplantation. 2024;108(4):911-922.
Bergom HE, Sena LA, Day A, Miller B, Miller CD, Lozada JR, et al. Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer. NPJ Genom Med. 2024;9(1):7.
Stenzl A, Armstrong AJ, Sboner A, Ghith J, Serfass L, Bland CS, et al. Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology. Eur Urol Focus. 2024;10(6):1011-1018.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700